Page 23 - Kirin Holdings Teaching Note
P. 23

A5  In 2014 Kirin had purchased a prominent stake in a

                       Japanese craft Brewer and it had also formed

                       international partnerships including one with a major

                       Brewer from New York. In Japan craft beer only

                       accounted for about 1% of the beer market whilst in

                       the US it was over 10%. Isozaki saw an opportunity

                       where in Japan craft beer could be just as big. In the

                       next five years he wanted to grow it to about 3% and
                       develop its overseas markets.



               Q6  “There are three kinds of intelligence: one kind

                       understands things for itself, the other appreciates what
                       others can understand, the third understands neither for
                       itself nor through others. This first kind is excellent, the

                       second good, and the third kind useless.”

                       In the above quote, and in terms of business

                       intelligence, where does Yoshinori Isozaki fit in the

                       directing of Kirin Holdings?





               A6  Isozaki is a change agent. He is attempting to build a

                       structure that redirects the company’s focus from a

                       quasi-single product company dependent upon mass

                       produced beer to a modern highly diversified company

                       operating in multiple market segments (both product

                       and geographic) underpinned by a philosophy of

                       created shared value. Part of his vision is to drive

                       innovation through developing the Business Creations

                       Division that draws on all aspects of the Group (R&D)
                       but bridges the applications between Food & Beverages


                       and Pharmaceuticals.
   18   19   20   21   22   23   24   25   26   27   28